Childhood Epilepsy Global Clinical Trials Review, H2, 2015

1
Childhood Epilepsy Global Clinical Trials Review,
H2, 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Childhood Epilepsy Global Clinical Trials Review,
  H2, 2015 provides an overview of Childhood
  Epilepsy clinical trials scenario. This report
  provides top line data relating to the clinical
  trials on Childhood Epilepsy. Report includes an
  overview of trial numbers and their average
  enrollment in top countries conducted across the
  globe. The report offers coverage of disease
  clinical trials by region, country (G7 E7),
  phase, trial status, end points status and
  sponsor type. Report also provides prominent
  drugs for in-progress trials (based on number of
  ongoing trials).
• Scope
• - The report provides a snapshot of the global
  clinical trials landscape
• - Report provides top level data related to the
  clinical trials by Region, Country (G7 E7),
  Trial Status, Trial Phase, Sponsor Type and End
  point status
• - The report reviews top companies involved and
  enlists all trials (Trial title, Phase, and
  Status) pertaining to the company
• - The report provides all the unaccomplished
  trials (Terminated, Suspended and Withdrawn) with
  reason for unaccomplishment
• - The Report provides enrollment trends for the
  past five years
• - Report provides latest news for the past three
  months
• Read More At http//www.researchbeam.com/childhoo
  d-epilepsy-global-clinical-trials-review-h2-2015-m
  arket

3


Table of Content
Table of Contents 2 List of Tables 3 List of
Figures 4 Report Guidance 5 Clinical Trials by
Region 6 Clinical Trials and Average Enrollment
by Country 7 Top Five Countries Contributing to
Clinical Trials in Asia-Pacific 10 Top Five
Countries Contributing to Clinical Trials in
Europe 11 Top Countries Contributing to Clinical
Trials in North America 12 Top Countries
Contributing to Clinical Trials in Middle East
and Africa 13 Clinical Trials by G7 Countries
Proportion of Childhood Epilepsy to Central
Nervous System Clinical Trials 14 Clinical Trials
by Phase in G7 Countries 15 Clinical Trials in G7
Countries by Trial Status 16 Clinical Trials by
E7 Countries Proportion of Childhood Epilepsy to
Central Nervous System Clinical Trials
17 Clinical Trials by Phase in E7 Countries
18 Clinical Trials in E7 Countries by Trial
Status 19 Clinical Trials by Phase 20 In Progress
Trials by Phase 21 Clinical Trials by Trial
Status 22
4


Table of Content
Clinical Trials by End Point Status 23 Subjects
Recruited Over a Period of Time 24 Clinical
Trials by Sponsor Type 25 Prominent Sponsors
26 Top Companies Participating in Childhood
Epilepsy Therapeutics Clinical Trials
27 Prominent Drugs 29 Latest Clinical Trials News
on Childhood Epilepsy 30 Nov 25, 2015 New
Epidiolex Data Accepted for Presentation at the
69th Annual Meeting of the American Epilepsy
Society 30 Clinical Trial Profile Snapshots
31 Appendix 96 Abbreviations 96 Definitions
96 Research Methodology 97 Secondary Research
97 About GlobalData 98 Contact Us 98 Disclaimer
98 Source 99 Enquire At http//www.researchbeam
.com/childhood-epilepsy-global-clinical-trials-rev
iew-h2-2015-market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/childhood-epilepsy-glo
bal-clinical-trials-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com